CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity Awards and Warrants - Private Placement of Shares of Common Stock and Warrants (Details)

Equity Awards and Warrants - Private Placement of Shares of Common Stock and Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended			3 Months Ended
	Sep. 30, 2023	Aug. 31, 2023	Jul. 31, 2023	Aug. 31, 2023	Jun. 30, 2023	Aug. 31, 2022	May 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of share		$ 0.50	$ 0.50	$ 0.50	$ 0.306
Exercise of warrants for cash				$ 300
Exercise of warrants for cash, shares				3,000,000.0
Common stock warrants to purchase shares		14,700,000	14,700,000	14,700,000
Term of warrants		5 years	5 years	5 years
Placement agent fees and expenses		$ 400	$ 400
Percentage of gross proceeds		12.00%	12.00%
Issuance of common stock for principal of convertible notes				$ 1,500
Proceeds from warrant exercises				$ 300		$ 264
Common Stock, Shares Authorized		1,350,000,000		1,350,000,000			1,350,000,000
Placement agent notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Placement agent fees and expenses					$ 200
Interest rate					6.00%
Private Equity Offering
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued for private offerings						$ 17,544
Accredited Investors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock warrants to purchase shares		14.7	14.7	14.7
Stock issued for private offerings		$ 2,600	$ 2,600
Accredited Investors \| Placement agent notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of share		$ 0.20		$ 0.20
Issuance of common stock for principal of convertible notes			$ 2,300
Warrants issued in debt conversion			11,500,000
Allotment to placement agent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of share		$ 0.20	$ 0.20	$ 0.20
Common stock warrants to purchase shares		2,200,000	2,200,000	2,200,000
Term of warrants		10 years	10 years	10 years
Placement agent fees and expenses		$ 5,000	$ 5,000
Percentage of gross proceeds		15.00%	15.00%
July Private Placement \| Placement agent notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares in a fixed combination issue of shares			1
Number of warrants in a fixed combination issue of securities			1
Number of shares			1
Closing share price (as percentage)			90.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of share		$ 0.10		$ 0.10
2012 Equity Incentive Plan \| Consultants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stocks issued for severance payment				533,124		324,600
Subsequent Event \| September Private Placement \| Placement agent notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of share	$ 0.50
Exercise price of stock warrant combo, per share	$ 0.20
Shares issued during the period new issues shares	2.5
Common stock warrants to purchase shares	2,500,000
Term of warrants	5 years
Number of common shares in a fixed combination issue of shares	1
Number of warrants in a fixed combination issue of securities	1
Number of shares	1
Stock issued for private offerings	$ 500
Proceeds from warrant exercises	$ 400
Closing share price (as percentage)	90.00%